These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 24532280)
1. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
3. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients. Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128 [TBL] [Abstract][Full Text] [Related]
6. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways. Liu Y; Zhou Y; Feng X; An P; Quan X; Wang H; Ye S; Yu C; He Y; Luo H Int J Oncol; 2014 Jan; 44(1):203-10. PubMed ID: 24189753 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation. Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932 [TBL] [Abstract][Full Text] [Related]
9. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer. Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
11. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer. Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284 [TBL] [Abstract][Full Text] [Related]
12. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-372 is associated with poor prognosis in colorectal cancer. Yamashita S; Yamamoto H; Mimori K; Nishida N; Takahashi H; Haraguchi N; Tanaka F; Shibata K; Sekimoto M; Ishii H; Doki Y; Mori M Oncology; 2012; 82(4):205-12. PubMed ID: 22456107 [TBL] [Abstract][Full Text] [Related]
14. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression. Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients. Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286 [TBL] [Abstract][Full Text] [Related]
17. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis. Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. Lou X; Qi X; Zhang Y; Long H; Yang J J Surg Oncol; 2013 Sep; 108(4):230-5. PubMed ID: 23861214 [TBL] [Abstract][Full Text] [Related]